Follow The Filings

HON Honeywell

Honeywell earnings company data as of 7:51 PM ET 10/29

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 22 Oct EPS 2.15 2.27 Beat +5.6%
Rev — $4.99B —

Insider trades

Open-market buys and sales by HON's executives, directors and 10% owners in the last 12 months, from their Form 4s

All HON insider trades
  • None no insider bought on the open market
  • $12.4M sold by 7 insiders outside a trading plan
  • $289K sold by 1 insider under 10b5-1 plans
  1. Su Ping Lu SrVP, General Counsel, CorpSec
    Sale
    $651K 2,943 shares at $221.18 31% of stake
    Traded Oct 26 Filed Oct 27
  2. Vimal Kapur CEO
    Sale
    $1.4M 6,459 shares at $220.99 59% of stake
    Traded Oct 26 Filed Oct 27
  3. Kenneth J West CEO
    Planned sale
    $78K 316 shares at $245.47 14% of stake
    Traded Aug 3 Filed Aug 3
  4. Kenneth J West CEO
    Sale
    $4.2M 17,032 shares at $243.77 89% of stake
    Traded Jul 27 Filed Jul 29
  5. Kenneth J West CEO
    Planned sale
    $212K 873 shares at $242.70 21% of stake
    Traded Mar 2 Filed Mar 3
  6. James E Currier CEO
    Sale
    $548K 2,248 shares at $243.65 33% of stake
    Traded Mar 2 Filed Mar 3
  7. Grace Lieblein Director
    Sale
    $1.4M 5,847 shares at $243.73 27% of stake
    Traded Feb 23 Filed Feb 24
  8. D Scott Davis Director
    Sale
    $568K 2,367 shares at $240.00 7.1% of stake
    Traded Feb 19 Filed Feb 20
  9. Robert D. Mailloux Vice President & Controller
    Sale
    $1.3M 5,274 shares at $239.00 52% of stake
    Traded Feb 6 Filed Feb 9
  10. Robert D. Mailloux Vice President & Controller
    Sale
    $2.4M 10,549 shares at $229.00 69% of stake
    Traded Jan 30 Filed Feb 3

Also filed in the last 12 months, not counted as buying or selling: 60 option exercises, 39 share withholdings for taxes, and 5 stock grants.

SEC filings

Recent issuer filings from EDGAR, 8 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
8-K 5.02,7.01,9.01
SCHEDULE 13G —
SCHEDULE 13G —
10-Q/A
8-K 2.02,9.01
10-Q

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.